"Platinum Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic compounds which contain platinum as the central atom.
Descriptor ID |
D017671
|
MeSH Number(s) |
D01.710
|
Concept/Terms |
Platinum Compounds- Platinum Compounds
- Compounds, Platinum
- Platinum Compounds, Inorganic
- Compounds, Inorganic Platinum
- Inorganic Platinum Compounds
|
Below are MeSH descriptors whose meaning is more general than "Platinum Compounds".
Below are MeSH descriptors whose meaning is more specific than "Platinum Compounds".
This graph shows the total number of publications written about "Platinum Compounds" by people in this website by year, and whether "Platinum Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2009 | 1 | 1 | 2 |
2010 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Platinum Compounds" by people in Profiles.
-
Chen J, Emara N, Solomides C, Parekh H, Simpkins H. Resistance to platinum-based chemotherapy in lung cancer cell lines. Cancer Chemother Pharmacol. 2010 Nov; 66(6):1103-11.
-
Flynn DC, Ramakrishna G, Yang HB, Northrop BH, Stang PJ, Goodson T. Ultrafast optical excitations in supramolecular metallacycles with charge transfer properties. J Am Chem Soc. 2010 Feb 03; 132(4):1348-58.
-
Martin LP, Schilder RJ. Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol. 2009 Apr; 36(2):112-25.
-
McWhinney SR, Goldberg RM, McLeod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther. 2009 Jan; 8(1):10-6.
-
Socinski MA, Morris DE, Masters GA, Lilenbaum R. Chemotherapeutic management of stage IV non-small cell lung cancer. Chest. 2003 Jan; 123(1 Suppl):226S-243S.
-
Jain N, Lam YM, Pym J, Campling BG. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Cancer. 1996 May 1; 77(9):1797-808.